(ABR) Arbor Realty Trust - Overview
Sector: Real Estate | Industry: REIT - Mortgage | Exchange: NYSE (USA) | Market Cap: 1.557m USD | Total Return: -29.3% in 12m
Avg Trading Vol: 25.9M USD
Peers RS (IBD): 10.4
EPS Trend: -70.2%
Qual. Beats: 0
Rev. Trend: 58.9%
Qual. Beats: 3
Arbor Realty Trust (ABR) is a real estate investment trust (REIT) focused on structured finance assets within the multifamily, single-family rental, and commercial real estate sectors in the United States. REITs are legally required to distribute a significant portion of their taxable income to shareholders.
The company operates through two segments: Structured Business and Agency Business. Its primary investments include bridge and mezzanine loans, preferred and direct equity, and real estate-related joint ventures. The business model involves providing short-term capital solutions for property acquisition and various forms of subordinate financing.
ABR also originates, sells, and services multifamily mortgage loans, often through conduit/commercial mortgage-backed securities programs. This involves packaging loans for sale to institutional investors.
To further your research, consider exploring ValueRay for detailed financial metrics and performance trends.
- Interest rate fluctuations impact loan demand and profitability
- Multifamily and commercial real estate market health drives asset performance
- Loan origination volume directly affects revenue growth
- Regulatory changes to REITs or real estate lending pose risks
| Net Income: 148.8m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.03 > 0.02 and ΔFCF/TA -0.85 > 1.0 |
| NWC/Revenue: -419.8% < 20% (prev 1.39k%; Δ -1.81k% < -1%) |
| CFO/TA 0.03 > 3% & CFO 372.4m > Net Income 148.8m |
| Net Debt (10.57b) to EBITDA (919.4m): 11.49 < 3 |
| Current Ratio: 0.10 > 1.5 & < 3 |
| Outstanding Shares: last quarter (212.5m) vs 12m ago 3.27% < -2% |
| Gross Margin: 92.15% > 18% (prev 0.90%; Δ 9.12k% > 0.5%) |
| Asset Turnover: 7.57% > 50% (prev 4.65%; Δ 2.92% > 0%) |
| Interest Coverage Ratio: 1.25 > 6 (EBITDA TTM 919.4m / Interest Expense TTM 701.8m) |
| A: -0.31 (Total Current Assets 482.9m - Total Current Liabilities 4.93b) / Total Assets 14.49b |
| B: -0.01 (Retained Earnings -136.6m / Total Assets 14.49b) |
| C: 0.06 (EBIT TTM 878.4m / Avg Total Assets 13.99b) |
| D: -0.01 (Book Value of Equity -134.6m / Total Liabilities 11.43b) |
| Altman-Z'' Score: -1.63 = D |
| DSRI: 0.00 (Receivables 6.53m/10.89b, Revenue 1.06b/627.5m) |
| GMI: 0.98 (GM 92.15% / 90.07%) |
| AQI: none (AQ_t none / AQ_t-1 none) |
| SGI: 1.69 (Revenue 1.06b / 627.5m) |
| TATA: -0.02 (NI 148.8m - CFO 372.4m) / TA 14.49b) |
| Beneish M-Score: cannot calculate (missing components) |
Over the past week, the price has changed by -3.03%, over one month by -3.92%, over three months by -1.95% and over the past year by -29.25%.
- StrongBuy: 0
- Buy: 1
- Hold: 1
- Sell: 2
- StrongSell: 0
| ISSUER | TARGET | UP/DOWN |
|---|---|---|
| Wallstreet Target Price | 8.9 | 20.8% |
| Analysts Target Price | 8.9 | 20.8% |
P/E Forward = 11.7371
P/S = 2.8558
P/B = 0.6119
P/EG = 1.6489
Revenue TTM = 1.06b USD
EBIT TTM = 878.4m USD
EBITDA TTM = 919.4m USD
Long Term Debt = 5.90b USD (from longTermDebt, last quarter)
Short Term Debt = 4.93b USD (from shortTermDebt, last quarter)
Debt = 11.05b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 10.57b USD (from netDebt column, last quarter)
Enterprise Value = 12.12b USD (1.56b + Debt 11.05b - CCE 482.9m)
Interest Coverage Ratio = 1.25 (Ebit TTM 878.4m / Interest Expense TTM 701.8m)
EV/FCF = 32.56x (Enterprise Value 12.12b / FCF TTM 372.4m)
FCF Yield = 3.07% (FCF TTM 372.4m / Enterprise Value 12.12b)
FCF Margin = 35.13% (FCF TTM 372.4m / Revenue TTM 1.06b)
Net Margin = 14.04% (Net Income TTM 148.8m / Revenue TTM 1.06b)
Gross Margin = 92.15% ((Revenue TTM 1.06b - Cost of Revenue TTM 83.2m) / Revenue TTM)
Gross Margin QoQ = 91.41% (prev 93.99%)
Tobins Q-Ratio = 0.84 (Enterprise Value 12.12b / Total Assets 14.49b)
Interest Expense / Debt = 1.63% (Interest Expense 180.3m / Debt 11.05b)
Taxrate = 13.84% (4.20m / 30.3m)
NOPAT = 756.9m (EBIT 878.4m * (1 - 13.84%))
Current Ratio = 0.10 (Total Current Assets 482.9m / Total Current Liabilities 4.93b)
Debt / Equity = 3.74 (Debt 11.05b / totalStockholderEquity, last quarter 2.95b)
Debt / EBITDA = 11.49 (Net Debt 10.57b / EBITDA 919.4m)
Debt / FCF = 28.38 (Net Debt 10.57b / FCF TTM 372.4m)
Total Stockholder Equity = 2.98b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.06% (Net Income 148.8m / Total Assets 14.49b)
RoE = 4.99% (Net Income TTM 148.8m / Total Stockholder Equity 2.98b)
RoCE = 9.89% (EBIT 878.4m / Capital Employed (Equity 2.98b + L.T.Debt 5.90b))
RoIC = 8.88% (NOPAT 756.9m / Invested Capital 8.52b)
WACC = 2.36% (E(1.56b)/V(12.61b) * Re(9.15%) + D(11.05b)/V(12.61b) * Rd(1.63%) * (1-Tc(0.14)))
Discount Rate = 9.15% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -2.36%
[DCF] Terminal Value 84.88% ; FCFF base≈408.1m ; Y1≈356.8m ; Y5≈289.4m
[DCF] Fair Price = N/A (negative equity: EV 8.75b - Net Debt 10.57b = -1.82b; debt exceeds intrinsic value)
EPS Correlation: -70.25 | EPS CAGR: -46.93% | SUE: -3.18 | # QB: 0
Revenue Correlation: 58.91 | Revenue CAGR: 21.27% | SUE: 4.0 | # QB: 3
EPS next Quarter (2026-06-30): EPS=0.16 | Chg7d=-0.040 | Chg30d=-0.040 | Revisions Net=-4 | Analysts=5
EPS current Year (2026-12-31): EPS=0.70 | Chg7d=-0.138 | Chg30d=-0.138 | Revisions Net=-3 | Growth EPS=-34.6% | Growth Revenue=+2.5%
EPS next Year (2027-12-31): EPS=1.00 | Chg7d=-0.028 | Chg30d=-0.028 | Revisions Net=-2 | Growth EPS=+42.4% | Growth Revenue=+2.3%
[Analyst] Revisions Ratio: -1.00 (0 Up / 4 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 1.5% (Discount Rate 9.2% - Earnings Yield 7.6%)
[Growth] Growth Spread = -14.7% (Analyst -13.1% - Implied 1.5%)